Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Myosarcoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Sarcoma
Myosarcoma

Subtype

Myosarcoma

CI-CAN-00001265Explore in graph →

106 active trials1 approved drugs38 evidence items

NCIt: C214801
MeSH: D009217

Overview
Statistics
Survival
Genomics4
Variants & evidence38
Drugs4
Trials325
Research
Rankings
Sources & provenance

Data completeness5 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

An aggressive mesenchymal neoplasm with malignant histopathological features that arises from smooth, skeletal, or cardiac muscle cells. This category includes leiomyosarcomas and rhabdomyosarcomas.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Malignant Muscle NeoplasmSubtype
Myomatous NeoplasmCancer Family
SarcomaCancer Family

Children (2)

ncit

Leiomyosarcoma35 sub
Rhabdomyosarcoma17 sub

149 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Connective and Soft TissueC3810

Record

Identity

CancerIndex ID: CI-CAN-00001265
Entity type: Subtype
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 4
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

325 / 106

Publications (all / 5y)

12,250 / 1,229

Evidence items

38

Genes / variants

9 / 12

Drugs (any / approved)

4 / 1

Genomic cohorts

4

Epidemiology / survival obs.

0 / 0

Data updated 4 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (3)

Myosarcomamesh_heading · MeSH
Malignant Myomatous Neoplasmsynonym · NCIt
Myosarcomassynonym · MeSH

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials106countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #185 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials58countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #180 of 1,284 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items38countaccepted CIViC items · entity + descendantscivicComputedrank #94 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months184countPubMed records · stored query · 12-month windowpubmedComputedrank #248 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts4countopen GDC projects · entity + descendantsgdcComputedrank #172 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 4 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants